Calidi Biotherapeutics, Inc.

First Light Acquisition Group, Inc. (Nasdaq: FLAG), sponsored by First Light Acquisition Group LLC, is a blank-check company that completed its IPO in 2021 targeting the healthcare and biotechnology sector. The February 2023 Form 8-K filing, bearing accession number 0001193125-23-032729, relates to the SPAC's proposed business combination with Calidi Biotherapeutics, Inc., a clinical-stage oncology company developing engineered stem-cell platforms to deliver oncolytic viruses as cancer therapeutics. The transaction subsequently closed in September 2023, with the combined company trading on NYSE American under the ticker CLDI. Sign up for SpacDesk to access full filing histories, deal timelines, and sponsor analytics on FLAG and hundreds of other SPACs.